Does a novel adaptive design strategy increase the efficiency of clinical trials in secondary progressive multiple sclerosis?
Although more complex in design, ASDs have the potential to be more efficient and more powerful than conventional designs.
In this study, we found no evidence for a role of gp150 in latency amplification. The previously observed contradictory results on the role of gp150 in latency amplification were not related to differences between the mutant viruses which had been used.